What is the recommended management of acute respiratory distress syndrome (ARDS) in a pregnant patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 16, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Management of ARDS in Pregnant Patients

Manage ARDS in pregnant patients using the same lung-protective ventilation strategies as non-pregnant patients, with low tidal volumes (4-8 mL/kg predicted body weight), plateau pressures ≤30 cm H₂O, and prone positioning for severe cases (PaO₂/FiO₂ <150), while prioritizing maternal survival as the primary determinant of fetal outcomes. 1

Core Ventilatory Management

The fundamental approach to ARDS in pregnancy does not differ from non-pregnant patients. Apply lung-protective ventilation immediately:

  • Tidal volumes: 4-8 mL/kg predicted body weight (calculate using pre-pregnancy height, not actual body weight) 1
  • Plateau pressure: ≤30 cm H₂O 1
  • Higher PEEP strategy for moderate-to-severe ARDS (conditional recommendation) 1, 2
  • Conservative fluid strategy once tissue perfusion is adequate 3

The evidence supporting these interventions comes from general ARDS populations, but maternal clinical indicators should guide treatment decisions as delay in ICU care carries an odds ratio of 2.3 for maternal mortality 4.

Prone Positioning

For severe ARDS (PaO₂/FiO₂ <150 or <100 mm Hg), use prone positioning for >12 hours daily 1. This is a strong recommendation with moderate-quality evidence in the general ARDS population and is explicitly indicated for pregnant women 5. The Proning Severe ARDS Patients trial showed no difference in complications between pregnant patients and other groups 5. Prone positioning is feasible even in advanced pregnancy and should not be withheld due to pregnancy status alone.

Adjunctive Therapies

Corticosteroids

Consider corticosteroids for moderate-to-severe ARDS within 14 days of onset 2. This represents updated guidance with a conditional recommendation based on moderate certainty evidence. Administration beyond 14 days may worsen outcomes 6.

Neuromuscular Blocking Agents

If neuromuscular blockade is required for severe ARDS (PaO₂/FiO₂ <150), use cisatracurium or rocuronium - these are the only pregnancy category B neuromuscular blocking agents 4. Avoid category C agents (vecuronium, atracurium, pancuronium) for prolonged infusion, especially in the first trimester 4. The decision to use neuromuscular blockade is justified when necessary to save the mother's life or avoid severe hypoxia for both mother and fetus 4.

Use for ≤48 hours in severe ARDS with PaO₂/FiO₂ <150 mm Hg 3, 2.

ECMO Consideration

For severe refractory ARDS, venovenous ECMO may be considered at experienced centers 2, 7. Recent data show maternal survival rates of 83% and fetal survival of 61% in pregnant/postpartum women on VV-ECMO for viral pneumonia-related ARDS 7. Major bleeding is the primary complication (38% of cases) and the leading cause of maternal death 7.

Critical Pitfalls to Avoid

  1. Do not delay standard ARDS management due to pregnancy concerns - critically ill obstetrical patients have an odds ratio of 12.9 for mortality from respiratory failure, and ARDS alone carries a 12% fetal loss rate 4

  2. Do not use high-frequency oscillatory ventilation - this has a strong recommendation against use in moderate-to-severe ARDS 1

  3. Avoid prolonged recruitment maneuvers - strong recommendation against their routine use 2

  4. Do not withhold prone positioning due to pregnancy - it is safe and effective even in advanced gestation 5

  5. Calculate tidal volumes using predicted body weight (pre-pregnancy height), not actual weight - this is essential for lung-protective ventilation 4

Monitoring and Supportive Care

  • Maintain head of bed elevation 30-45 degrees to prevent ventilator-associated pneumonia 3
  • Implement spontaneous breathing trials regularly when criteria are met (arousable, hemodynamically stable without vasopressors, low ventilatory requirements) 3
  • Avoid routine pulmonary artery catheterization 3, 1
  • Do not use β-2 agonists routinely unless bronchospasm is present 3

Delivery Considerations

Delivery timing should be based on maternal stability and fetal viability, not as a primary treatment for ARDS. However, some patients show rapid respiratory improvement after delivery 8. The decision requires individualized multidisciplinary assessment balancing gestational age, maternal respiratory status, and fetal well-being 9, 8.

The overarching principle: maternal survival is paramount, as it directly determines fetal outcomes. Standard evidence-based ARDS management should not be compromised due to pregnancy status 4, 9.

References

6
Research

Emergency medicine updates: Acute respiratory distress Syndrome.

The American journal of emergency medicine, 2025

Related Questions

What is the appropriate management for a patient with acute respiratory distress syndrome (ARDS) and shock?
For a pregnant woman who presented with acute respiratory distress, was appropriately treated and is now stable for discharge, which medication should be prescribed at discharge?
What were the results and clinical recommendations of the ARMA trial (NEJM 2000) regarding low tidal volume ventilation in adult patients with acute respiratory distress syndrome?
What are the differences between acute respiratory distress syndrome (ARDS) and heart failure?
In a patient with severe acute respiratory distress syndrome on day 10 who has been kept supine, should I initiate an airway pressure release ventilation (APRV) trial with spontaneous breathing?
What lactulose dosing regimen should be used for a patient with AST 98 U/L, ALT 126 U/L, and ammonia 78 µmol/L?
What oral medications are recommended for treating supraventricular tachycardia in an adult without structural heart disease?
What is the recommended dose of cefdinir (Omnicef) for treating epididymitis in an adult?
How is upper airway resistance syndrome (UARS) during sleep diagnosed and treated?
Can I consume a non-red Celsius energy drink during colonoscopy preparation?
What is the differential diagnosis for acute medial knee pain that is tender to light touch without erythema, swelling, or preceding injury?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.